Skip to content

Prospective cohort study of aggressive ATL

Prospective cohort study of aggressive ATL - ATL cohort 2014

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000017672
Enrollment
100
Registered
2015-05-25
Start date
2015-01-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ATLL

Interventions

None listed

Sponsors

National Cancer Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of aggressive ATLL 2. Less than 6 months after diagnosis of aggressive ATLL 3. 70 years old or younger 4. Informed consent

Exclusion criteria

Exclusion criteria: 1. Relapsed ATLL 2. 6 months or more after diagnosis of aggressive ATLL 3. active other cancer 4. pregnant 5. psychiatric disorder 6. inappropriate for this study

Design outcomes

Primary

MeasureTime frame
2-year overall survival after diagnosis of aggressive ATLL

Countries

Japan

Contacts

Public ContactShigeo Fuji

National Cancer Center Hospital Division of Hematopoietic Stem Cell Transplantation

sfuji@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026